@BioStocks
Investor/trader focused primarily in the biopharma sector. Tweets are not investment advice and are not recommendations of any kind.
World & Business
CNBC reports Keytruda Qlex brought in $830 million in quarterly sales, topping the $649 million StreetAccount estimate.
